Medicine and Dentistry
Cancer Cell
48%
Breast Cancer
45%
Malignant Neoplasm
45%
Metastatic Carcinoma
40%
Neoplasm
33%
Cancer Testis Antigen
31%
Cancer
27%
Triple Negative Breast Cancer
21%
Tumor Progression
19%
Primary Tumor
18%
Tumor Microenvironment
18%
DNA Methyltransferase
18%
Hormone Therapy
18%
Non Small Cell Lung Cancer
18%
Cancer Stem Cell
18%
CDK4/6 Inhibitor
18%
Protein Kinase B
18%
Neutrophil
18%
Xenograft
18%
Melanoma
16%
DNA Methyltransferase Inhibitor
15%
Tumor Cell
15%
Antineoplastic Activity
13%
Epidermal Growth Factor Receptor
10%
Extracellular Trap
10%
Immunotherapy
10%
Host Cell
10%
Ectopic Expression
10%
Small Interfering RNA
10%
Ex Vivo
9%
Cancer Types
9%
In Vitro
9%
p38 Mitogen-Activated Protein Kinase
9%
Histone Deacetylase Inhibitor
9%
Addictive Behavior
9%
Adenine Nucleotide Translocase
9%
Peripheral Lymphocyte
9%
MAPK Signaling
9%
Transfer Cell
9%
Aurora B Kinase
9%
Immunosuppressive Drug
9%
Mitochondrion
9%
Mitogen-Activated Protein Kinase
9%
Distant Metastasis
9%
Interleukin 1
9%
Cancer Growth
9%
DNA Damage
9%
Cholesterol Synthesis
9%
Tyrosine-Kinase Inhibitor
9%
Immune System
9%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
100%
Cancer Stem Cell
28%
Tumor Progression
27%
Proteomics
22%
Carcinogenesis
21%
SSX2
20%
Mitochondrion
19%
Myeloid
19%
Interleukin-1
18%
HMGA2
18%
DNA Methyltransferase
18%
Programmed Cell Death
13%
Gene Signature
13%
Quantitative Proteomics
13%
Antineoplastic Activity
13%
Estrogen Receptor
11%
Cell Invasion
11%
Genome Instability
10%
MicroRNA
10%
Epigenetics
10%
Protein Kinase B
10%
Mouse Model
10%
Biological Phenomena and Functions Concerning the Entire Organism
10%
Small Interfering RNA
10%
Ectopic Expression
10%
P53
10%
Anticancer
9%
Cell-Cell Interaction
9%
Fibroblast Growth Factor Receptor 1
9%
Heterochromatin
9%
MiR-155
9%
Overall Survival
9%
MAPK Signaling
9%
Mediator Complex
9%
Epidermal Growth Factor Receptor
9%
Chromosome 1
9%
CD44
9%
Drug Screening
9%
Mitochondrial Membrane Transport Protein
9%
Mitogen-Activated Protein Kinase
9%
Translocase
9%
Peripheral Blood Lymphocyte
9%
Genetic Screen
9%
DNA Damage
9%
Tyrosine Kinase Inhibitor
9%
Exosite
9%
Disease Free Survival
9%
Aptamer
9%
Dissociation Constant
9%
Active Site
9%
Immunology and Microbiology
Cancer Cell
40%
Xenograft
23%
Tumor Cell
21%
Antineoplastic Activity
19%
Myeloid-Derived Suppressor Cell
18%
Cell Surface
17%
Neutrophil Extracellular Traps
11%
Immunosuppressive Drug
11%
Epitope
11%
Internalization
10%
Proteomics
10%
Neutrophil
10%
Immunocompetent Cell
10%
Cell Invasion
9%
Cancer Testis Antigen
9%
Interleukin 1
9%
Myeloid
9%
Antibody Drug Conjugate
9%
Bispecific Antibody
9%
Monoclonal Antibody
9%
Mitochondrion
9%
Histone
9%
Myosin
9%
MAPK Signaling
9%
Immune System
9%
Smooth Muscle Cell
9%
Pyruvate Dehydrogenase
9%
Immunotherapy
7%
Cell Line
6%
Circulating Tumor Cell
6%
Cancer Cell Line
6%
T Cell
5%
Breast Cancer Cell Line
5%
